Analysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (BTAI) and Unity Biotechnology (UBX)

TipRanksApr 16 06:31 ET

Express News | BioXcel Therapeutics Announced Details Regarding The Planned Design Of Its Upcoming TRANQUILITY In-care Phase 3 Trial Of BXCL501 For Agitation Associated With Alzheimer's Dementia

Moomoo 24/7Apr 10 07:06 ET

BioXcel Therapeutics(BTAI.US) Officer Sells US$2,811.54 in Common Stock

$BioXcel Therapeutics(BTAI.US)$ Officer Yocca Frank sold 1,067 shares of common stock on Apr 4, 2024 at an average price of $2.635 for a total value of $2,811.54.Source: Announcement What is statement

moomoo NewsApr 8 20:12 ET

BioXcel Therapeutics(BTAI.US) Officer Sells US$2,667.43 in Common Stock

$BioXcel Therapeutics(BTAI.US)$ Officer Rodriguez Javier sold 1,012 shares of common stock on Apr 4, 2024 at an average price of $2.6358 for a total value of $2,667.43.Source: Announcement What is sta

moomoo NewsApr 8 20:12 ET

BioXcel Therapeutics(BTAI.US) Officer Sells US$2,816.81 in Common Stock

$BioXcel Therapeutics(BTAI.US)$ Officer Steinhart Richard I sold 1,069 shares of common stock on Apr 4, 2024 at an average price of $2.635 for a total value of $2,816.81.Source: Announcement What is s

moomoo NewsApr 8 20:12 ET

BioXcel Therapeutics(BTAI.US) Officer Sells US$2,656.18 in Common Stock

$BioXcel Therapeutics(BTAI.US)$ Officer Wiley Matthew T. sold 1,008 shares of common stock on Apr 4, 2024 at an average price of $2.6351 for a total value of $2,656.18.Source: Announcement What is sta

moomoo NewsApr 8 20:12 ET